ArticleJACC. Case reports2026
Thoracoabdominal Aortic Aneurysm Treated With a Novel Off-the-Shelf Device: A First-in-Human Experience.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative analysis of the postoperative effectiveness of different splenic artery aneurysm embolization techniques.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndovascular repair of thoracoabdominal aortic aneurysms (TAAAs) is constrained by 2 critical limitations: delays associated with custom-made devices and the inherent risk of endoleaks. CASE SUMMARY: A patient with type III TAAA. We used a novel bifurcated stent graft system (BSGS; LifeTech Scientific) to reconstruct 4 visceral arteries, thereby successfully isolating the TAAA. DISCUSSION: The BSGS eliminates delays related to custom device fabrication and demonstrates promising safety and efficacy in the endovascular treatment of complex TAAAs. TAKE-HOME MESSAGES: TAAAs pose significant challenges for endovascular treatment due to involvement of all visceral arteries. This case demonstrated the endovascular treatment of TAAAs using a novel off-the-shelf device, with a method akin to "building with blocks."
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.